第一秒用力呼气量的最小重要差异与最小可检测差异？寻找独角兽。 - Suppr

Suppr

超能文献

FEV Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn.

作者信息

Crim Courtney, Frith Lucy J, Midwinter Dawn, Donohue James F

机构信息

GlaxoSmithKline plc Research Triangle Park, North Carolina and.

University of North Carolina at Chapel Hill Chapel Hill, North Carolina.

出版信息

Am J Respir Crit Care Med. 2021 Jun 15;203(12):1573-1576. doi: 10.1164/rccm.202012-4322LE.

DOI:10.1164/rccm.202012-4322LE

PMID:33751925

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8483219/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a17c/8483219/9d33e9fa9b61/rccm.202012-4322LEf1.jpg

相似文献

FEV Minimum Important Difference versus Minimal Detectable Difference? In Search of the Unicorn.第一秒用力呼气量的最小重要差异与最小可检测差异？寻找独角兽。

Am J Respir Crit Care Med. 2021 Jun 15;203(12):1573-1576. doi: 10.1164/rccm.202012-4322LE.

Comparison of Forced and Slow Vital Capacity Maneuvers in Defining Airway Obstruction.用力和缓慢肺活量测定在定义气道阻塞中的比较。

Respir Care. 2019 Jul;64(7):786-792. doi: 10.4187/respcare.06419. Epub 2019 Mar 19.

Determinants of CAT (COPD Assessment Test) scores in a population of patients with COPD in central and Eastern Europe: The POPE study.中东北欧地区 COPD 患者 CAT（COPD 评估测试）评分的决定因素：POPE 研究。

Respir Med. 2019 Apr;150:141-148. doi: 10.1016/j.rmed.2019.03.007. Epub 2019 Mar 21.

Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.一秒用力呼气容积与用力肺活量的支气管扩张剂反应、慢性阻塞性肺疾病加重和死亡率的关系。

Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC.

Association between vitamin D status and asthma control: A meta-analysis of randomized trials.维生素 D 状态与哮喘控制的关系：一项随机试验的荟萃分析。

Respir Med. 2019 Apr;150:85-94. doi: 10.1016/j.rmed.2019.02.016. Epub 2019 Feb 21.

Characteristics of Alpha-1 Antitrypsin-Deficient Individuals in the Long-term Oxygen Treatment Trial and Comparison with Other Subjects with Chronic Obstructive Pulmonary Disease.长期氧疗试验中α-1抗胰蛋白酶缺乏个体的特征及其与其他慢性阻塞性肺疾病患者的比较。

Ann Am Thorac Soc. 2015 Dec;12(12):1796-804. doi: 10.1513/AnnalsATS.201506-389OC.

Does lobectomy for lung cancer in patients with chronic obstructive pulmonary disease affect lung function? A multicenter national study.慢性阻塞性肺疾病患者行肺癌肺叶切除术会影响肺功能吗？一项全国性多中心研究。

J Thorac Cardiovasc Surg. 2005 Dec;130(6):1616-22. doi: 10.1016/j.jtcvs.2005.06.049.

Minimum clinically important difference in diffusing capacity of the lungs for carbon monoxide among patients with severe and very severe chronic obstructive pulmonary disease.重度和极重度慢性阻塞性肺疾病患者一氧化碳肺弥散量的最小临床重要差异

COPD. 2015 Feb;12(1):31-7. doi: 10.3109/15412555.2014.898051. Epub 2014 Jun 10.

Minimal clinically important differences in COPD lung function.慢性阻塞性肺疾病（COPD）肺功能的最小临床重要差异

COPD. 2005 Mar;2(1):111-24. doi: 10.1081/copd-200053377.

Minimal Important and Detectable Differences of Respiratory Measures in Outpatients with AECOPD.慢性阻塞性肺疾病急性加重期门诊患者呼吸指标的最小重要差异和可检测差异

COPD. 2018 Oct;15(5):479-488. doi: 10.1080/15412555.2018.1537366. Epub 2018 Dec 4.

引用本文的文献

Systematic review and meta‑analysis of factors predicting postoperative lung function after lung cancer resection.肺癌切除术后预测肺功能的因素的系统评价与Meta分析

Wideochir Inne Tech Maloinwazyjne. 2024 Jul 31;19(3):289-298. doi: 10.20452/wiitm.2024.17892. eCollection 2024 Oct 16.

Pharmacokinetic modeling of prenatal vitamin D exposure and the impact on offspring asthma and pulmonary function.产前维生素D暴露的药代动力学建模及其对后代哮喘和肺功能的影响。

Biomed Pharmacother. 2025 Feb;183:117859. doi: 10.1016/j.biopha.2025.117859. Epub 2025 Jan 27.

Supplementary Respiratory Therapy Improves Pulmonary Function in Pediatric Patients with Cerebral Palsy: A Systematic Review and Meta-Analysis.辅助呼吸治疗改善脑瘫患儿的肺功能：一项系统评价和荟萃分析

J Clin Med. 2024 Feb 2;13(3):888. doi: 10.3390/jcm13030888.

IL-33 receptor inhibition in subjects with uncontrolled asthma: A randomized, placebo-controlled trial.在未控制哮喘患者中抑制白细胞介素-33受体：一项随机、安慰剂对照试验。

J Allergy Clin Immunol Glob. 2022 Aug 17;1(4):198-208. doi: 10.1016/j.jacig.2022.07.002. eCollection 2022 Nov.

Effectiveness of a training program for a patient with non-cardiac chest pain that combines intervention to improve quality of life, psychological state, and functional capacity: a case report.一项针对非心源性胸痛患者的培训计划的有效性，该计划结合了改善生活质量、心理状态和功能能力的干预措施：病例报告。

Biopsychosoc Med. 2023 Jul 26;17(1):27. doi: 10.1186/s13030-023-00283-4.

Relationship between gut microbiota and lung function decline in patients with chronic obstructive pulmonary disease: a 1-year follow-up study.肠道微生物群与慢性阻塞性肺疾病患者肺功能下降的关系：一项为期 1 年的随访研究。

Respir Res. 2022 Jan 15;23(1):10. doi: 10.1186/s12931-022-01928-8.

本文引用的文献

Treatment response in COPD: does FEV say it all? A analysis of the CRYSTAL study.慢性阻塞性肺疾病（COPD）的治疗反应：FEV能说明一切吗？CRYSTAL研究的分析

ERJ Open Res. 2019 Feb 25;5(1). doi: 10.1183/23120541.00243-2018. eCollection 2019 Feb.

Prevention of clinically important deteriorations in COPD with umeclidinium/vilanterol.使用乌美溴铵/维兰特罗预防慢性阻塞性肺疾病的临床重要恶化。

Int J Chron Obstruct Pulmon Dis. 2016 Jun 24;11:1413-24. doi: 10.2147/COPD.S101612. eCollection 2016.

Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials.每日 1 次吸入氟替卡松维兰特罗和维兰特罗单药治疗用于 COPD 恶化预防的比较：两项复制的双盲、平行组、随机对照试验。

Lancet Respir Med. 2013 May;1(3):210-23. doi: 10.1016/S2213-2600(13)70040-7. Epub 2013 Apr 12.

Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results.脉冲震荡法测定健康人和 COPD 患者呼吸系统阻抗：ECLIPSE 基线结果。

Respir Med. 2011 Jul;105(7):1069-78. doi: 10.1016/j.rmed.2011.01.010. Epub 2011 Apr 11.

Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review.稳定期 COPD 患者吸入性支气管扩张剂随机试验中 FEV1 变化与患者报告结局的关系：系统评价。

Respir Res. 2011 Apr 8;12(1):40. doi: 10.1186/1465-9921-12-40.

Susceptibility to exacerbation in chronic obstructive pulmonary disease.慢性阻塞性肺疾病恶化的易感性。

N Engl J Med. 2010 Sep 16;363(12):1128-38. doi: 10.1056/NEJMoa0909883.

Minimal clinically important differences in COPD lung function.慢性阻塞性肺疾病（COPD）肺功能的最小临床重要差异

COPD. 2005 Mar;2(1):111-24. doi: 10.1081/copd-200053377.

Interpretative strategies for lung function tests.肺功能测试的解读策略。

Eur Respir J. 2005 Nov;26(5):948-68. doi: 10.1183/09031936.05.00035205.

Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.慢性阻塞性肺疾病患者的诊断和治疗标准：美国胸科学会/欧洲呼吸学会立场文件摘要

Eur Respir J. 2004 Jun;23(6):932-46. doi: 10.1183/09031936.04.00014304.

Spirometry and dyspnea in patients with COPD. When small differences mean little.慢性阻塞性肺疾病患者的肺量测定与呼吸困难。当微小差异意义不大时。

Chest. 1996 May;109(5):1163-8. doi: 10.1378/chest.109.5.1163.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验